Accelerated Pharma, Inc.

Biopharma start-ups brought in nearly two-and-a-half times as much funding in the fourth quarter as in the third quarter. Novartis AG was one of five big pharma companies to pen an alliance with a

Rhythm Pharmaceuticals Inc. , Deciphera Pharmaceuticals LLC , NuCana PLC and Adial Pharmaceuticals Inc. all registered their intent to launch initial public offerings in September, potentially

Two biopharmaceutical companies launched similar initial public offerings in the US within a day of each other – G1 Therapeutics Inc. on May 16 and argenx SE on May 17 – and raised more than $

US initial public offerings by biopharmaceutical companies in the second quarter already outnumber the first quarter with IPOs from Ovid Therapeutics Inc. , UroGen Pharma Ltd. and Biohaven Ph